相关实验视频

Updated: Jan 9, 2026

Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach

Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach

Published on: June 5, 2010

针对异形性炎症性肌肉病的向治疗

Ruijie Wang¹, Wei Lin¹, Qibing Xie¹

¹Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Journal of cachexia, sarcopenia and muscle

|December 10, 2025

概括

向疗法正在改变固态炎症肌肉病 (IIM) 的治疗方法,为耐火性疾病患者提供了新的希望. 这些先进的治疗方法,包括B细胞疗法和JAK抑制剂,在改善患者的治疗结果方面显示出显著的前景.

科学领域:

免疫学免疫学免疫学
类风湿病学类风湿病学
药理学药理学是指药理学的学科.

背景情况:

异常性炎症性肌肉病变 (IIM) 是一种自身免疫性疾病,导致慢性肌肉炎症和肌肉外问题.
许多患者有耐药性或复发性疾病,尽管标准的免疫抑制.
需要新的向治疗方法,进步识别新的治疗点.

研究的目的:

审查针对异常性炎症性肌肉病 (IIM) 的向治疗的现有证据.
综合各种向治疗的有效性和安全性的数据.
突出IIM管理的最新进展和未来方向.

主要方法:

在PubMed,Cochrane图书馆和谷歌学者的系统文献搜索到2025年9月.
包括随机对照试验,观察性研究,元分析和病例报告.
对IIM亚型的疗效,安全性和结果的综合证据.

主要成果:

向疗法正在彻底改变IIM管理,像rituximab这样的B细胞疗法是耐火病例的基石.
简氏激酶 (JAK) 抑制剂在皮肤和肺部表现方面表现出有效性.
新兴疗法包括Fc受体对抗性和先进的细胞疗法,如CAR-T细胞疗法,在严重病例中显示持续缓解.

结论:

针对IIM的向治疗的景观正在迅速发展,允许更精确,更有效的患者管理.
这些策略为改善耐火性IIM患者的治疗结果提供了显著的希望.
未来的研究应该优先考虑治疗选择的生物标志物发现,更大的临床试验和长期安全监测.

关键词:

卡特 - 卡特 - 卡特 - 卡特生物产品是生物产品.异形性炎症性肌肉病变 (Idiopathic Inflammatory Myopathies) 是一种异形性炎症性肌肉病变 (Idiopathic Inflammatory Myopathies) 的一种疾病.免疫疗法免疫疗法分子向疗法是指分子向疗法.肌肉性肌肉性炎症肌肉性肌肉炎

更多相关视频

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

相关概念视频

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...